Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China · Delayed Price · Currency is CNY 26.64
-0.38 (-1.41%)
Apr 21, 2026, 3:04 PM CST
SHE:002880 Market Cap
SHE:002880 has a market cap or net worth of 6.04 billion as of April 21, 2026. Its market cap has decreased by -1.55% in one year.
Market Cap
6.04B
Enterprise Value
6.68B
Revenue
1.14B
Ranking
n/a
PE Ratio
26.42
Stock Price
26.64
Market Cap Chart
Since June 16, 2017, SHE:002880's market cap has increased from 3.91B to 6.04B, an increase of 54.71%. That is a compound annual growth rate of 5.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 6.13B | 5.96% |
| Dec 31, 2025 | 5.78B | -5.59% |
| Dec 31, 2024 | 6.13B | -23.11% |
| Dec 29, 2023 | 7.97B | 10.16% |
| Dec 30, 2022 | 7.23B | -0.90% |
| Dec 31, 2021 | 7.30B | -6.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 6.59B |
| Lifecome Biochemistry | 6.24B |
| Shouyao Holdings (Beijing) Co., LTD. | 6.24B |
| Kexing Biopharm | 6.17B |
| Beijing Scitop Bio-tech | 6.12B |
| Innovita Biological Technology | 6.04B |
| Novogene | 5.86B |
| Beijing Konruns Pharmaceutical | 5.80B |